Home > Insider Trading > Filing (0001138723-19-000045)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138723	Accuray Inc	ARAY	Surgical & Medical Instruments & Apparatus (3841)	770268932

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1756775	Jesse Chew	1310 Chesapeake Terrace Sunnyvale CA 94089	Svp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-10-31	373	$2.61	36,067	No	4	S	Direct
Common Stock	Acquisiton	2019-10-31	55,480	$0.00	91,547	No	4	A	Direct
Common Stock	Disposition	2019-11-01	1,770	$2.57	89,777	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2019-10-31	122,360	$0.00	122,360	$2.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
122,360		2029-10-31	No	4	A	Direct

Footnotes

Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
The restricted stock units (RSUs) are released at vest. At total of 34% of the shares subject to this grant become vested and are released on the first anniversary of the vesting commencement date and the remaining shares vest and are released at a rate of 33% on the second anniversary and 33% on the third anniversary of the commencement date.
The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.